The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 881-886

  Nikzamir, Abdolrahim ^a   Esteghamati, Alireza ^b   Hammedian, Amir Abbas ^c   Mahmoudi, Touraj ^d  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

+405 G C polymorphism; Albuminuria; Gene polymorphism; Vascular endothelial growth factor

Indexed keywords

HEMOGLOBIN A1C; VASCULOTROPIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; PRIMER DNA; VASCULOTROPIN A;

ADULT; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DNA BASE COMPOSITION; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; DIABETIC NEPHROPATHY; GENETICS; METABOLISM; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; URINE;

ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA PRIMERS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IRAN; LOGISTIC MODELS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860321146     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0812-4     Document Type: Article

References (47)

1. Held PJ, Port FK, Webb RL et al (1991) The United States Renal Data System's (1991) annual data report: an introduction. Am J Kidney Dis 18:1-16
2. Kretzler M, Schroppel B, Merkle M et al (1998) Detection of multiple vascular endothelial growth factor splice isoforms in single glomerular podocytes. Kidney Int Suppl 67:S159-S161 (Pubitemid 28405703)
3. Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown F (1996) Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 7: 661-666 (Pubitemid 27465997)
4. Ziyadeh FN, Guo J (2004) Mediators of diabetic renal disease: the case for TGF-beta as the major mediator. J Am Soc Nephrol 15(Suppl 1):S55-S57 (Pubitemid 38018457)
5. Singh DK, Winocour P, Farrington K (2008) Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol 4:216-226 (Pubitemid 351451302)
6. Vasavada N, Agarwal R (2005) Role of oxidative stress in diabetic nephropathy. Adv Chronic Kidney Dis 12:146-154 (Pubitemid 40488997)
7. Raptis AE, Viberti G (2001) Pathogenesis of diabetic nephropa-thy. Exp Clin Endocrinol Diabetes 109(Suppl 2):S424-S437
8. WuL W, Mayo LD, Dunbar JD et al (2000) Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 275:5096-5103 (Pubitemid 30108910)
9. Hohenstein B, Hausknecht B, Boehmer K et al (2006) Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 69:1654-1661
10. De Vriese AS, Tilton RG, Elger M et al (2001) Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12:993-1000 (Pubitemid 32378340)
11. Kanesaki Y, Suzuki D, Uehara G et al (2005) Vascular endo-thelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis 45:288-294 (Pubitemid 40431054)
12. Satchell SC, Harper SJ, Mathieson PW (2004) Angiopoietin 1 and vascular endothelial growth factor modulate human glo-merular endothelial cell barrier properties. J Am Soc Nephrol 15:566-574 (Pubitemid 38294786)
13. Tsilibary EC (2003) Microvascular basement membranes in diabetes mellitus. J Pathol 200:537-546 (Pubitemid 36818254)
14. Sharma K, Ziyadeh FN (1995) Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146
15. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS et al (2002) Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51:3090-3094
16. Wolf G, Chen S, Ziyadeh FN et al (2005) From the periphery of the glomerular capillary wall toward the center of disease: pod-ocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626-1634 (Pubitemid 40770751)
17. Eremina V, Miner JH et al (2006) Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 17:724-735
18. Rutledge JC, Ng KF, Aung HH et al (2010) Role of triglyceride-rich lipoproteins in diabetic nephropathy. Nat Rev Nephrol 6:361-370
19. Adler S (2004) Diabetic nephropathy: linking histology, cell biology, and genetics. Kidney Int 66:2095-2106
20. American Diabetes Association (2005) Diagnosis and classification of diabetes mellitus. Diabetes Care 28:S37-S42
21. Gentilini D, Somigliana E, Vigano P et al (2008) The vascular endothelial growth factor 405G/C polymorphism in endometri-osis. Hum Reprod 23(1):211-215 (Pubitemid 351767316)
22. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25 (Pubitemid 27076453)
23. Murata T, Ishibashi K, Khalil A et al (1995) Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthal Res 27:48-52
24. Ferrara N (1995) Vascular endothelial growth factor: the trigger for neovascularization in the eye. Lab Invest 72:615-618
25. Witmer AN, Vrensen GF, Van Noorden CJF et al (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22:1-29 (Pubitemid 36207453)
26. Summers AM, Coupes BM et al (2005) VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrol Dial Transplant 20:2427-2432 (Pubitemid 41548867)
27. SchrIjvers BF, Flyvbjerg A, De Vriese A (2004) The role of vascular endothelial growth factor (VEGF) in renal pathophysi-ology. Kidney Int 65(6):2003-2017 (Pubitemid 38669987)
28. Cooper ME, Anderson S, Brenner BM et al (1998) Pathogenesis prevention and treatment of diabetic nephropathy. Lancet 352: 213-219 (Pubitemid 28327814)
29. Ichinose K, Kawasaki E, Eguchi K et al (2007) Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy. Am J Nephrol 27(6):554-564 (Pubitemid 350014942)
30. Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I et al (2007) Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol Dial Transplant 22:827-832 (Pubitemid 46351692)
31. Ray D, Mishra M, Ralph S, Read J et al (2004) Association of the VEGF gene with proliferative diabetic retinopathy but not pro-teinuria in diabetes. Diabetes 53:861-864 (Pubitemid 38270661)
32. Grone HJ, Miller JW, Adamis AP et al (1995) Angiogenesis and vascular endothelial growth factor (VEGF): is it relevant in renal patients? Nephrol Dial Transplant 10:761-763
33. Awata T, Inoue K, Kurihara S et al (2002) A common polymorphism in the 50-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51:1635-1639 (Pubitemid 34826636)
34. De Vriese AS, Verbeuren TJ, Van de Voorde J et al (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130:963-974 (Pubitemid 30453529)
35. Aiello LP, Wong J-S (2000) Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl 77:S113-S119
36. Doi K, Noiri E, Nakao A, Fujita T et al (2006) Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. J Am Soc Nephrol 17(3):823-830
37. Watson CJ, Webb NJA, Bottomley MJ et al (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12:1232-1235 (Pubitemid 30611801)
38. Cha DR, Kim NH, Yoon JW et al (2000) Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int Suppl 77:S104-S112
39. Chiarelli F, Spagnoli A, Basciani F et al (2000) Vascular endo-thelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications. Diabet Med 17:650-656
40. Tavakkoly-Bazzaz J, Amoli MM, Pravica V et al (2010) VEGF gene polymorphism association with diabetic neuropathy. Mol Biol Rep 37(7):3625-3630
41. Summers AM, Coupes BM, Brennan MF et al (2005) VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrol Dial Transplant 20:2427-2432 (Pubitemid 41548867)
42. Trevisan R, Viberti G (1995) Genetic factors in the development of diabetic nephropathy. J Lab Clin Med 126:342-349
43. Pettitt DJ, Robbins DC et al (1990) Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438-443 (Pubitemid 20220945)
44. Lijima K, Yoshikawa N, Connolly DT et al (1993) Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 44:959-966 (Pubitemid 23316463)
45. De Vriese AS, Tilton RG, Elger M et al (2001) Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12:993-1000 (Pubitemid 32378340)
46. Lenz T, Haak T, Malek J et al (2003) Vascular endothelial growth factor in diabetic nephropathy. Kidney Blood Press Res 26(5-6): 338-343 (Pubitemid 37465042)
47. Yang JW, Hutchinson IV, Shah T et al (2011) Gene polymorphism of vascular endothelial growth factor -1154 G[A is associated with hypertensive nephropathy in a Hispanic population. Mol Biol Rep 38(4):2417-2425